Literature DB >> 15625381

Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease.

Ewa Koscielniak, Ute Gross-Wieltsch, Joern Treuner, Peter Winkler, Thomas Klingebiel, Peter Lang, Peter Bader, Dietrich Niethammer, Rupert Handgretinger.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15625381     DOI： 10.1200/JCO.2005.05.940

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic stem cell transplantation in the treatment of adrenal cancer with multiple metastases.

Authors:  Osamu Imataki; Atsushi Makimoto; Rie Kojima; Michiyo Sakiyama; Ako Hosono; Yoichi Takaue
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 2.  Review of Chinese clinical trials on CIK cell treatment for malignancies.

Authors:  Xiao-Dong Li; Bin Xu; Jun Wu; Mei Ji; Bei-Hua Xu; Jing-Ting Jiang; Chang-Ping Wu
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

3.  Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients.

Authors:  P Schlegel; T Feuchtinger; C Nitschke-Gérard; U J Eva Seidel; A-M Lang; C Kyzirakos; H-M Teltschik; M Ebinger; M Schumm; E Koscielniak; R Handgretinger; P Lang
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Authors:  David Schirmer; Thomas G P Grünewald; Richard Klar; Oxana Schmidt; Dirk Wohlleber; Rebeca Alba Rubío; Wolfgang Uckert; Uwe Thiel; Felix Bohne; Dirk H Busch; Angela M Krackhardt; Stefan Burdach; Günther H S Richter
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

5.  Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Authors:  Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

6.  Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

Authors:  Kristin Baird; Terry J Fry; Seth M Steinberg; Michael R Bishop; Daniel H Fowler; Cynthia P Delbrook; Jennifer L Humphrey; Alison Rager; Kelly Richards; Alan S Wayne; Crystal L Mackall
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-05       Impact factor: 5.742

7.  Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors.

Authors:  David R Shook; Brandon M Triplett; Ashok Srinivasan; Christine Hartford; Mari H Dallas; Asha Pillai; Joseph Laver; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-09       Impact factor: 5.742

8.  Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation.

Authors:  Christian M Capitini; Joanne Derdak; Marybeth S Hughes; Cynthia P Love; Kristin Baird; Crystal L Mackall; Terry J Fry
Journal:  J Pediatr Hematol Oncol       Date:  2009-02       Impact factor: 1.289

9.  Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.

Authors:  U Thiel; S Pirson; C Müller-Spahn; H Conrad; D H Busch; H Bernhard; S Burdach; G H S Richter
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

10.  Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.

Authors:  U Thiel; E Koscielniak; F Blaeschke; T G P Grunewald; M Badoglio; M A Diaz; C Paillard; A Prete; M Ussowicz; P Lang; F Fagioli; P Lutz; G Ehninger; P Schneider; A Santucci; P Bader; B Gruhn; M Faraci; P Antunovic; J Styczynski; W H Krüger; L Castagna; P Rohrlich; M Ouachée-Chardin; A Salmon; C Peters; M Bregni; S Burdach
Journal:  Br J Cancer       Date:  2013-10-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.